HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-κB activation

American Journal of Physiology

Volumn 279, Issue 6 PART 2, 2000, Pages

  Kan, Hong ^a   Xie, Zirong ^a   Finkel, Mitchell S ^a,b,c,d  

^a Department of Medicine ^*  (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell signaling; Cytokines; Heart; Human immunodeficiency virus; Nitric oxide

Indexed keywords

EID: 0034535477     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Anderson DW, Virmani R, and Reilly JM. Prevalence myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 11: 792-799, 1988.
2. Bagetta G, Corasaniti MT, Berliocchi L, Nistico R, Giammarioli AM, Malorni W, Aloe L, and Finazzi-Agro A. Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience 89: 1051-1066, 1999.
3. Barbaro G, Di Lorenzo G, Grisorio B, and Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardium of HIV-positive patients. N Engl J Med 339: 1093-1099, 1998.
4. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Grisorio B, Pellicelli A, and Barbarini G. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruoppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation 100: 933-939, 1999.
5. 2+channel in rabbit ventricular myocytes (Abstract). J Am Coll Cardiol 35: 225, 2000.
6. Cook SA, Sugden PH, and Clerk A. Activation of c-jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 31: 1429-1434, 1999.
7. Herskowitz A, Willoughby SB, Vlahov D, Baughman KL, and Ansari AA. Dilated heart muscle disease associated with HIV infection. Eur Heart J 16: 50-55, 1995.
8. Huang CF and Su MJ. Positive inotropic action of NMDA receptor antagonist (+)-MK801 in rat heart. J Biomed Sci 6: 387-398, 1999.
9. Kacimi R, Long CS, and Karliner JS. Chronic hypoxia modulates the interleukin-1β-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation 96: 1937-1943, 1997.
10. Kan H, Xie Z, and Finkel MS. Norepinephrine stimulated MAP kinase activity enhances cytokine induced nitric oxide production by neonatal rat cardiac myocytes. Am J Physiol Heart Circ Physiol 276: H47-H52, 1999.
11. Kan H, Xie Z, and Finkel MS. TNF-α enhances cardiac myocyte NO production through MAP-kinase-mediated NF-κB activation. Am J Physiol Heart Circ Physiol 277: H1641-H1646, 1999.
12. Kozak SL, Kuhmann SE, Platt EJ, and Kabat D. Role of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1. J Biol Chem 274: 23499-23507, 1999.
13. Kumar A, Middleton A, Chambers TC, and Mehta KD. Differential role of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1β- and tumor necrosis factor-α-induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 273: 15742-15748, 1998.
14. Lannuzel A, Barnier JV, Hery C, Huynh VT, Guibert B, Gray F, Vincent JD, and Tardieu M. Human immunodeficiencey virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol 42: 847-856, 1997.
15. Lipton SA. AIDS-related dementia and calcium homeostasis. Ann NY Acad Sci 747: 205-224, 1994.
16. Oddis CV and Finkel MS. Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem Biophys Res Commun 213: 1002-1009, 1995.
17. Oddis CV and Finkel MS. NF-κB and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes. Am J Physiol Heart Circ Physiol 270: H1864-H1868, 1996.
18. Oddis CV, Simmons RL, Hattler BG, and Finkel MS. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol Heart Circ Physiol 269: H2044-H2050, 1995.
19. Roberts AB, Vodovotz Y, Roche AS, Sporn MB, and Nathan CF. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol Endocrinol 6: 1921-1930, 1995.
20. Rozanski GJ and Witt RC. IL-1 inhibites β-adrenergic control of cardiac calcium current: role of L-arginine/nitric oxide pathway. Am J Physiol Heart Circ Physiol 267: H1753-H1758, 1994.
21. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM, Billiar TR, and Geller DA. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273: 15148-15156, 1998.
22. Wahler GM and Dollinger SJ. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol Cell Physiol 268: C45-C54, 1995.
23. Xin KQ, Hamajima K, Hattori S, Cao XR, Kawamoto S, and Okuda K. Evidence of HIV type I glycoprotein 120 binding to recombinant N-methyl-D-aspartate receptor subunits expressed in a baculovirus system. AIDS Res Hum Retroviruses 15: 1461-1467, 1999.
24. Ye ZS and Samuels HH. Cell- and sequence-specific binding of nuclear protein to 5′-flanking DNA of the rat growth hormone gene. J Biol Chem 262: 6313-6317, 1987.